These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30300288)

  • 41. Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States.
    Rana A; Brewer ED; Scully BB; Kueht ML; Goss M; Halazun KJ; Liu H; Galvan NT; Cotton RT; O'Mahony CA
    Pediatr Nephrol; 2017 Apr; 32(4):669-678. PubMed ID: 27757587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of Multiple Listing for Adult Heart Transplantation in the United States: Analysis of OPTN Data From 2000 to 2013.
    Givens RC; Dardas T; Clerkin KJ; Restaino S; Schulze PC; Mancini DM
    JACC Heart Fail; 2015 Dec; 3(12):933-41. PubMed ID: 26577617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Risk of Death for Patients on the Waitlist for Liver Transplant Residing at Greater Distance From Specialized Liver Transplant Centers in the United States.
    Cicalese L; Shirafkan A; Jennings K; Zorzi D; Rastellini C
    Transplantation; 2016 Oct; 100(10):2146-52. PubMed ID: 27490419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement.
    Perito ER; Roll G; Dodge JL; Rhee S; Roberts JP
    Transplantation; 2019 Mar; 103(3):552-557. PubMed ID: 29684000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low body mass index is associated with increased waitlist mortality among children listed for heart transplant.
    Davies RR; Haldeman S; McCulloch MA; Gidding SS; Pizarro C
    J Heart Lung Transplant; 2015 Nov; 34(11):1462-70. PubMed ID: 26212660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
    Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Trinh PN; Yuzefpolskaya M; Farr MA; Naka Y; Colombo PC; Topkara VK
    Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of Waitlist Mortality in Adult Heart Transplant Candidates: The Candidate Risk Score.
    Jasseron C; Legeai C; Jacquelinet C; Leprince P; Cantrelle C; Audry B; Porcher R; Bastien O; Dorent R
    Transplantation; 2017 Sep; 101(9):2175-2182. PubMed ID: 28272288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive Function, Access to Kidney Transplantation, and Waitlist Mortality Among Kidney Transplant Candidates With or Without Diabetes.
    Chu NM; Shi Z; Haugen CE; Norman SP; Gross AL; Brennan DC; Carlson MC; Segev DL; McAdams-DeMarco MA
    Am J Kidney Dis; 2020 Jul; 76(1):72-81. PubMed ID: 32029264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Kensinger CD; Feurer ID; Karp SJ
    Transplantation; 2017 Sep; 101(9):2056-2061. PubMed ID: 28471871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of conversion to active waitlist status among temporarily inactive obese renal transplant candidates.
    Huang E; Shye M; Elashoff D; Mehrnia A; Bunnapradist S
    Transplantation; 2014 Jul; 98(2):177-86. PubMed ID: 24608735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mathematical model to describe survival among liver recipients from deceased donors with risk of transmitting infectious encephalitis pathogens.
    Smalley HK; Anand N; Buczek D; Buczek N; Lin T; Rajore T; Wacker M; Basavaraju SV; Gurbaxani BM; Hammett T; Keskinocak P; Sokol J; Kuehnert MJ
    Transpl Infect Dis; 2019 Aug; 21(4):e13115. PubMed ID: 31102550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.
    Shudo Y; Cohen JE; Lingala B; He H; Zhu Y; Woo YJ
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):603-610. PubMed ID: 30669225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.
    Henson JB; Patel YA; Wilder JM; Zheng J; Chow SC; King LY; Muir AJ
    Dig Dis Sci; 2017 Nov; 62(11):3200-3209. PubMed ID: 28391417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list.
    Kardashian AA; Dodge JL; Roberts J; Brandman D
    Liver Int; 2018 Mar; 38(3):553-563. PubMed ID: 28727287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates.
    Kerbert AJC; Reverter E; Verbruggen L; Tieleman M; Navasa M; Mertens BJA; Rodríguez-Tajes S; de Vree M; Metselaar HJ; Chiang FWT; Verspaget HW; van Hoek B; Bosch J; Coenraad MJ
    Clin Transplant; 2018 Nov; 32(11):e13412. PubMed ID: 30230613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Hogen R; Lo M; DiNorcia J; Ji L; Genyk Y; Sher L; Dhanireddy K
    Transplantation; 2019 Apr; 103(4):747-754. PubMed ID: 29672442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
    Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
    Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Elderly Allografts in Liver Transplantation.
    Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
    Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.